Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Supernus to acquire Sage Therapeutics for postpartum depression drug

June 17, 2025

Supernus Pharmaceuticals is acquiring Sage Therapeutics for up to $795 million, adding the FDA-approved postpartum depression treatment Zurzuvae to its portfolio. The acquisition follows a series...

BioNTech acquires CureVac to consolidate mRNA oncology efforts

June 17, 2025

BioNTech has finalized an all-stock acquisition of CureVac valued at approximately $1.25 billion, bringing the German mRNA vaccine competitor under its umbrella as a subsidiary. The merger...

AI and machine learning advancements in biotech drug development

June 17, 2025

Recent developments highlight the expanding role of AI and machine learning in accelerating drug discovery and diagnostic capabilities. University of Sheffield and AstraZeneca unveiled MapDiff, an...

New diagnostic and therapeutic technologies in oncology and infectious diseases

June 17, 2025

Innovations in diagnostics and treatments are advancing rapidly. King's College London researchers developed a nanoneedle patch offering painless tissue molecular sampling, potentially replacing...

Clinical and translational advances in neonatal care and pulmonary diseases

June 17, 2025

Significant progress has been made in understanding and managing neonatal and pulmonary conditions. A study elucidated cardiorespiratory improvements following transcatheter closure of patent...

Regulatory and funding landscape shifts impacting biotech innovation

June 17, 2025

Biotech innovation faces evolving regulatory and financing environments. FDA Commissioner Marty Makary is planning further agency consolidations aimed at operational efficiency amid staffing...

Gene editing and CRISPR patent disputes advance

June 17, 2025

The ongoing legal battle over CRISPR-Cas9 patent rights has taken a new turn following a US appeals court decision favoring the University of California and University of Vienna. The ruling...

Breakthroughs in molecular biology and cancer research tools

June 17, 2025

Advances in molecular tools and algorithms are propelling cancer and biomedical research. TACIT, a novel AI-driven algorithm developed by Virginia Commonwealth University, accelerates cell-type...

Emerging therapies and diagnostics in metabolic and autoimmune diseases

June 17, 2025

Recent clinical and preclinical research showcases novel treatment developments. A South Korean biotech disclosed promising MASH trial results for its dual GLP-1/glucagon receptor agonist with...

Sarepta Gene Therapy Halted After Second Liver Failure Death

June 17, 2025

Sarepta Therapeutics has suspended shipments of its gene therapy Elevidys for Duchenne muscular dystrophy (DMD) in non-ambulatory patients after a second fatal case of acute liver failure was...

Supernus Acquires Sage Therapeutics to Expand CNS Portfolio

June 17, 2025

Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics for approximately $561 million upfront, plus contingent value rights potentially increasing the deal to $795 million. The...

Breakthrough AI Tool Uncovers Hidden Protein Variants for Precision Medicine

June 17, 2025

Researchers at UCLA and the University of Toronto introduced moPepGen, an advanced computational algorithm improving detection of hidden genetic mutations at the protein level. The tool excels by...

Novel Nanoneedle Patch Offers Painless Alternative to Tissue Biopsies

June 17, 2025

Scientists at King’s College London have developed a nanoneedle patch containing tens of millions of microscopic silicon needles, thousands of times thinner than a human hair, that collects...

AI-Powered Technologies Advance Drug Development and Diagnostics

June 17, 2025

Several AI-driven innovations are propelling biotech forward. CSPC Pharmaceutical and AstraZeneca launched a $5.3 billion preclinical drug R&D collaboration leveraging CSPC’s AI drug discovery...

NIH Funds Research into PFAS Impact on Male Reproductive Health

June 17, 2025

A new two-year research initiative funded by the NIH’s National Institute of Environmental Health Sciences is investigating molecular mechanisms by which per- and polyfluoroalkyl substances (PFAS)...

Advances in Neonatal Cardiorespiratory and Lung Disease Research

June 17, 2025

Recent studies reveal critical insights into neonatal health. Researchers demonstrated that transcatheter closure of patent ductus arteriosus (PDA) in preterm infants significantly improves...

AI Innovations Enhance Clinical and Wildlife Monitoring

June 17, 2025

New AI methodologies demonstrate impact across diverse biomedical and ecological areas. At Emory University, a first-in-human trial employing dissolvable microarray patches for rotavirus...

Regulatory and Funding Landscape Shifts in Biotech R&D

June 17, 2025

Biotech regulation and financing are evolving amid innovation and institutional adjustments. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) implemented new postmarket...

CRISPR Patent Dispute Rekindled by Appeals Court

June 17, 2025

The University of California and University of Vienna secured a court ruling that has revived their challenge for key patents on CRISPR–Cas9 gene-editing technology, originally awarded to the...

Sarepta Gene Therapy Halted After Second Liver Failure Death

June 16, 2025

Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, specifically for non-ambulatory patients following a second fatal case of acute liver...